Skip to main content

The originating document has been archived. We cannot confirm the completeness, accuracy and currency of the content.




ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Sedative agent

Histamine H₁-receptor antagonist (H₁-antihistaminic)

Chemical Names

10-(3-Quinuclidinylmetyl)phenotiazine (WHO)

10H-Phenotiazine, 10-(1-azabicyclo[2.2.2]oct-3-ylmetyl)-

Foreign Names

  • Mequitazinum (Latin)
  • Mequitazin (German)
  • Méquitazine (French)
  • Mequitazina (Spanish)

Generic Names

  • Mequitazina (OS: DCIT)
  • Mequitazine (OS: JAN, BAN)
  • Méquitazine (OS: DCF)
  • LM 209 (IS)
  • Mequitazine (PH: JP XVII)

Brand Names

  • Aliman
    Sawai Seiyaku, Japan
  • Baymin
    Ta Fong, Taiwan
  • Benanzal
    Koa Isei, Japan
  • Brikemin
    Patron, Taiwan
  • Ceacnalon
    Taisho Yakuhin, Japan
  • Demine
    Newai Chem, Taiwan
  • Ecomin
    Johnson, Taiwan
  • Halemunin
    Tatsumi Kagaku, Japan
  • Hisporan
    Towa Yakuhin, Japan
  • Lomin
    Chen Ta, Taiwan
  • Meki a h
    Borg, Egypt
  • Mekin
    Shou Chan, Taiwan
  • Mekitazenon
    Nichi-Iko Pharmaceutical, Japan
  • Menber
    Hua Shin, Taiwan
  • Meqazine
    Hua Shin, Taiwan; Yuan Chou, Taiwan
  • Mequimin
    Kojar, Taiwan
  • Mequit
    Yu Sheng, Taiwan
  • Mequitamin
    Daito, Japan
  • Mequitazine 0.6% Taiyo
    Teva Seiyaku, Japan
  • Mequitazine DS 0.6% KN
    Kobayashi Kako, Japan
  • Mequitazine Nichi-Iko
    Nichi-Iko Pharmaceutical, Japan
  • Mequitazine Sinphar
    Sinphar, Taiwan
  • Mequitazine TCK
    Tatsumi Kagaku, Japan
  • Mequitazine Tsuruhara
    Tsuruhara Seiyaku Pharmaceutical, Japan
  • Mequitazine U.C. Pharma
    U.C. Pharma, Taiwan
  • Mequitine
    Winston, Taiwan
  • Minieton
    Swiss Pharm, Taiwan
  • Mining
    Tai Yu, Taiwan
  • Mino
    Everest, Taiwan
  • Minro
    Chin Teng Pharmaceutical Industrial, Taiwan
  • Mircol
    Italfarmaco, Spain
  • Nipolazin
    Alfresa Pharma, Japan
  • Nipolazin 0.03%
    Alfresa Pharma, Japan
  • Nipolazin 0.6%
    Alfresa Pharma, Japan
  • Primalan
    ADWYA, Tunisia; Pierre Fabre, Kuwait; Pierre Fabre, Lebanon; Pierre Fabre, Portugal; Pierre Fabre Médicament, France; Pierre-Fabre, Mexico; Rhone, Egypt; Rovafarm, Argentina
  • Primalan Fort
    ADWYA, Tunisia
  • Squmin
    Standard, Taiwan
  • Zesulan
    Asahi Kasei Pharma, Japan
  • Zesulan 0.6%
    Asahi Kasei Pharma, Japan


BANBritish Approved Name
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.